Abstract

Erratum: Zur E. Topical Treatment of Primary Focal Hyperhidrosis, Part 2. IJPC 2019; 23(2):94-104.

Author(s):

Issue: Jul/Aug 2019 - Volume 23, Number 4

Page(s): 351

Download in electronic PDF format for $75
  • Erratum: Zur E. Topical Treatment of Primary Focal Hyperhidrosis, Part 2. IJPC 2019; 23(2):94-104. Page 1

Abstract

Related Keywords

  • errata
  • errata

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Jul/Aug 2019
Pg. 351
Erratum: Zur E. Topical Treatment of Primary Focal Hyperhidrosis, Part 2. IJPC 2019; 23(2):94-104.
Author(s):
Mar/Apr 2019
Pg. 94-104
Topical Treatment of Primary Focal Hyperhidrosis, Part 2
Author(s): Zur Eyal
Jan/Feb 2019
Pg. 23-31
Topical Treatment of Primary Focal Hyperhidrosis, Part 1
Author(s): Zur Eyal
Jul/Aug 2019
Pg. 351
Erratum: Kiselova O, Maurina B, Sidlovska V et al. Trends of Extemporaneous Drug Prescription in Latvia in 2017. IJPC 2019; 23(3): 245-249.
Author(s):
May/Jun 2018
Pg. 263
Erratum: Formulation: Lansoprazole 3-mg/mL Oral Suspension
Author(s):
Mar/Apr 2011
Pg. 175
Erratum: Stability of Venlafaxine Immediate-Release Suspensions
Author(s): Allen Loyd V Jr
Mar/Apr 2006
Pg. 82
Erratum: Allen LV Jr. Lidocaine hydrochloride 2%, misoprostol 0.0024%, and phenytoin 2% topical wound powder. IJPC 2004; 8(4): 298
Author(s): Allen Loyd V Jr
Jan/Feb 2020
Pg. 86-87
View Sample
Errata - How to Qualify Container Closure Systems for Intended Use, Part 1 - IJPC 23(6) 454-461
Author(s):
Jul/Aug 2004
Pg. 269-274
Current Topical Treatments in Wound Healing - Part 1
Author(s): Helmke Christopher D
Jan/Feb 2013
Pg. 86
Errata
Author(s): Allen Loyd V Jr
Nov/Dec 2018
Pg. 527
Errata
Author(s): Allen Loyd V Jr
Mar/Apr 2025
Pg. 121
Erratum - Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration
Author(s):
Jul/Aug 2003
Pg. 266-270
Sensitization Therapy for Warts
Author(s): Kuntz Rachael
Jan/Feb 2001
Pg. 28-29
Topical Therapy for Localized Hyperhidrosis
Author(s): Glasnapp Andrew
Jul/Aug 2003
Pg. 288-291
Basics of Compounding for Raynaud's Disease
Author(s): Glasnapp Andrew
Jan/Feb 2020
Pg. 7-12
Primary Engineering Controls in Pharmaceutical Compounding, Part 2: Biosafety Cabinets
Author(s): Mulder Kyle
May/Jun 2019
Pg. 188-191
Summary of Educational Offerings Provided by Compounding Support Companies in 2019
Author(s): Stevens J Tyler
Sep/Oct 2019
Pg. 438
Erratum: Stevens JT. Summary of educational offerings provided by compounding support companies in 2019. IJPC. 2019; 23(3): 188–191.
Author(s):
Sep/Oct 2019
Pg. 366-375
Topical Treatment of Cutaneous Leishmaniasis in Israel, Part 3
Author(s): Zur Eyal
May/Jun 2019
Pg. 200-207
Topical Treatment of Cutaneous Leishmaniasis in Israel, Part 1
Author(s): Zur Eyal